Treatment of Post-bariatric Hypoglycaemia

NCT04836273 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Hyperinsulinemic Hypoglycemia
Postprandial Hypoglycemia

Interventions

DRUG: Dasiglucagon
DEVICE: HyoPen
DRUG: Placebo

Sponsor

Filip Krag Knop

Collaborators

[object Object]